HIGH · 7.7

CVE-2022-26389

An improper access control vulnerability may allow privilege escalation.This issue affects:  * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior;  * ELI 280/BUR280/MLBUR 280 Resting...

Vulnerability Description

An improper access control vulnerability may allow privilege escalation.This issue affects:  * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior;  * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior;  * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior;  * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

CVSS Score

7.7

HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H
Attack Vector
NETWORK
Attack Complexity
HIGH
Privileges Required
LOW
User Interaction
NONE
Scope
CHANGED
Confidentiality
LOW
Integrity
LOW
Availability
HIGH

Related Weaknesses (CWE)

References

FAQ

What is CVE-2022-26389?

CVE-2022-26389 is a vulnerability with a CVSS score of 7.7 (HIGH). An improper access control vulnerability may allow privilege escalation.This issue affects:  * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior;  * ELI 280/BUR280/MLBUR 280 Resting...

How severe is CVE-2022-26389?

CVE-2022-26389 has been rated HIGH with a CVSS base score of 7.7/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-26389?

Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.